Compare PTGX & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | CUBI |
|---|---|---|
| Founded | 2006 | 1994 |
| Country | United States | United States |
| Employees | N/A | 869 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 2.6B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | CUBI |
|---|---|---|
| Price | $102.40 | $72.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $108.23 | $85.00 |
| AVG Volume (30 Days) | ★ 523.0K | 301.9K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $874.25 | $24.95 |
| Revenue Next Year | N/A | $9.50 |
| P/E Ratio | $2,101.20 | ★ $11.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.15 | $49.76 |
| 52 Week High | $107.84 | $82.56 |
| Indicator | PTGX | CUBI |
|---|---|---|
| Relative Strength Index (RSI) | 51.80 | 42.24 |
| Support Level | $96.20 | $72.29 |
| Resistance Level | $107.42 | $72.45 |
| Average True Range (ATR) | 4.12 | 2.08 |
| MACD | 0.22 | -0.75 |
| Stochastic Oscillator | 61.93 | 8.93 |
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.